The Stan Bowley Trust was founded in memory of Stan Bowley, a beloved husband, father, and friend who lost his battle with cancer. Determined to honor his legacy, his family and friends established the Trust to support cancer patients and advance innovative treatments. One of the key areas the Trust focuses on is the promotion and funding of CyberKnife technology, a revolutionary treatment that has transformed the landscape of cancer care.

CyberKnife is a non-invasive, robotic radiation therapy system designed to treat tumors with pinpoint accuracy. Unlike traditional radiation therapy, which can affect surrounding healthy tissue, CyberKnife delivers high doses of radiation directly to the tumor, minimising damage to nearby organs and tissues. This precision is particularly beneficial for treating hard-to-reach or inoperable tumors, offering new hope to patients who previously had limited options.

The benefits of CyberKnife are profound. Patients experience fewer side effects compared to conventional radiation therapy, and the treatment is typically completed in just a few sessions. This means less disruption to their daily lives and a quicker return to normal activities. For many, CyberKnife represents a lifeline, providing effective treatment with a higher quality of life.

The Stan Bowley Trust has been instrumental in raising awareness about CyberKnife and making this cutting-edge technology accessible to more patients. Through fundraising efforts, such as the "365 in 25" campaign, the Trust has been able to support the installation of CyberKnife systems in hospitals and clinics, ensuring that more people can benefit from this life-saving treatment.

One such success story is that of Sarah, a young mother diagnosed with a brain tumor. Traditional surgery was deemed too risky due to the tumor's location. However, thanks to the Stan Bowley Trust's efforts, Sarah was able to receive CyberKnife treatment. The precision of the CyberKnife allowed doctors to target her tumor effectively, and within a few sessions, the tumor had significantly shrunk. Sarah experienced minimal side effects and was able to continue caring for her children throughout her treatment.

For children undergoing CyberKnife treatment, a custom plastic mask is often required to ensure they remain still during the procedure. These masks, which cost only £20 each, are crucial for the accuracy and effectiveness of the treatment. The Stan Bowley Trust has also focused on funding these masks, ensuring that young patients receive the best possible care without additional financial burden on their families.

Stories like Sarah's highlight the incredible impact of the Stan Bowley Trust and the benefits of CyberKnife. By supporting the Trust, donors are not only honoring Stan Bowley's memory but also contributing to a future where cancer patients have access to the most advanced and effective treatments available. Together, we can continue to make a difference in the fight against cancer, one life at a time.